MMP9 and neoplasm: Conversely, the cyclic LRSG peptide [CQVTGALRSGRGKMLLC-NH2, derived from MMP-9 HPX domain residues 615–622] inhibited MMP-9 interaction with the α5β1 integrin, tumor cell invasion, and cell surface gelatinolytic activity [40].